Anavex Life Sciences Corp. (FRA:12X1)

Anavex Life Sciences Statistics

Total Valuation

FRA:12X1 has a market cap or net worth of EUR 324.08 million. The enterprise value is 212.25 million.

Market Cap	324.08M
Enterprise Value	212.25M

Important Dates

The last earnings date was Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	92.67M
Shares Outstanding	n/a
Shares Change (YoY)	+2.61%
Shares Change (QoQ)	+3.65%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	89.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.01
P/TBV Ratio	3.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.24
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.87

Current Ratio	20.87
Quick Ratio	20.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.63% and return on invested capital (ROIC) is -23.33%.

Return on Equity (ROE)	-33.63%
Return on Assets (ROA)	-21.56%
Return on Invested Capital (ROIC)	-23.33%
Return on Capital Employed (ROCE)	-35.01%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.00M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:12X1 has paid 15,331 in taxes.

Income Tax	15,331
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-58.98%
50-Day Moving Average	3.56
200-Day Moving Average	6.42
Relative Strength Index (RSI)	45.11
Average Volume (20 Days)	234

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.76M
Pretax Income	-34.01M
Net Income	-34.02M
EBITDA	n/a
EBIT	-37.76M
Earnings Per Share (EPS)	-0.39

Balance Sheet

The company has 112.21 million in cash and n/a in debt, with a net cash position of 112.21 million.

Cash & Cash Equivalents	112.21M
Total Debt	n/a
Net Cash	112.21M
Net Cash Per Share	n/a
Equity (Book Value)	107.84M
Book Value Per Share	1.16
Working Capital	107.84M

Cash Flow

Operating Cash Flow	-29.02M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:12X1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.61%
Shareholder Yield	-2.61%
Earnings Yield	-10.50%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2